Medical Device Industry Regulatory and Quality Consultants
The consultants at Medical Devices and Pharma have decades of aggregated experience working with a variety of medical devices. That includes expert knowledge of regulations from the U.S. Food and Drug Administration (FDA), Health Canada (HC), the European Union (EU) and other global regulatory bodies.
We offer current information about new and novel medical devices, device safety alerts, industry news, and enforcement actions like FDA warning letters. Our regulatory specialists can expertly compile, prepare, and submit regulatory submissions for regulatory marketing authorization, like an FDA 510(k) premarket submission.
What is a medical device?
The definition of a medical device encompasses a wide range of complexity and purposes, from a walking cane to an artificial heart. It can be a physical apparatus or something like software or a chemical reagent.
Regardless of its form or composition, a product is defined as a medical device if it is used to diagnose a medical issue; alleviate, prevent or minimize the risk of a medical problem; or to provide medical treatment.
The differences between medical devices and pharmaceuticals.
Is your product a medical device?
Let us answer your questions about your medical device product, from device classification and requirements to establishment registration and device listings and requirements you need to follow in order to market the product in the U.S. Click here to contact us.
FDA definition of a medical device
An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is:
- Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them,
- Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or
- Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and
- Which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.
The term “device” does not include software functions excluded pursuant to section 520(o). Source: “Is the Product a Medical Device?“
Pre-amendment and post-amendment devices
Devices are also identified as pre-amendment or post-amendment based on when they received FDA market clearance. This makes a difference for how a manufacturer can put a device on the U.S. market.
Pre-amendment devices were on the market prior to the enactment of the Medical Device Amendments (MDA) of the Food, Drug and Cosmetic Act on May 28, 1976. They do not require a premarket approval (PMA) or premarket notification (510(k)) submission prior to market entry.
Post-amendment devices received marketing approval after the enactment of the MDA in 1976. Class III devices require the FDA approval of a PMA before the device can be sold on the market. Most class II and some class I devices require a 510(k) premarket notification submission to demonstrate that they are substantially equivalent to a medical device that is currently marketed in the U.S.
Medical Device Headlines
One Contaminated Alcohol Pad, Multiple Recalls
A Lesson in Medical Device Supply Chain Quality At first glance, Cardinal Health's recent recall of Webcol™ Alcohol Prep Pads appears straightforward. A commonly used healthcare product was found to be contaminated with Paenibacillus phoenicis, creating a potential...
Early Alert: Windstone Medical Recall for Convenience Kits
FDA Warns of Convenience Kits Containing Recalled Cardinal Health Alcohol Pads The FDA has issued an Early Alert regarding several medical convenience kits distributed by Windstone Medical Packaging, Inc. that contain alcohol prep pads previously recalled by Cardinal...
FDA Issues Warning Letter for Modifications to Infant Products
FDA Issues Warning Letter to Happiest Baby Over SNOO Smart Sleeper Modifications and Quality System Deficiencies The U.S. Food and Drug Administration has issued a Warning Letter to Happiest Baby, Inc., manufacturer of the SNOO Smart Sleeper, citing unapproved device...
FDA Expands Draeger Atlan Anesthesia Workstation Correction
More anesthesia machines added to correction for potential ventilation failure The U.S. Food and Drug Administration (FDA) has designated a recent expansion of Draeger, Inc.'s Atlan anesthesia workstation correction as a Class I recall, the agency's most serious...
Warning Letter to Zoll Medical for Major QMS Violations
Warning Letter to Zoll Medical for Major QMS Violations The U.S. Food and Drug Administration has issued a Warning Letter to ZOLL Medical Corporation citing significant Quality System Regulation (QSR) violations involving corrective and preventive action (CAPA),...
Abiomed Issues Correction for Automated Impella Controllers
Hardware Updates Required to Address Potential Loss of Hemodynamic Support Abiomed has issued a correction for certain Automated Impella Controllers (AICs) used with the Impella heart pump system after identifying hardware-related issues that could lead to controller...
FDA Clears First OTC Continuous Glucose Monitor for Children
Regulatory Snapshot Device: Stelo® Glucose Biosensor System (Dexcom, Inc.)Indication: Continuous glucose monitoring for individuals ages 2 years and older who do not use insulin, including children with diabetes managed through oral medications and individuals seeking...
FDA Early Alert for Baxter Pressure Breathing Device
FDA Issues Early Alert for Baxter Volara System Patient Circuits Following Therapy Leakage Concerns The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potentially high-risk issue affecting certain Baxter Volara System patient circuits...
FDA-Approved Vivistim: A New Pathway in Stroke Recovery
Vivistim implantable vagus nerve stimulator. Source: Vivistim.com.FDA-Approved Vagus Nerve Stimulation Device Opens a New Pathway in Stroke Recovery A company behind one of the world’s most closely watched neurorehabilitation technologies is preparing for a major new...
FDA Warning Letter Cites Systemic Aseptic Manufacturing Failures
Medline Warning Letter Signals Systemic Quality Failures in Cardiovascular Device Manufacturing The FDA has issued a Warning Letter to Medline Industries (NAMIC Division) following a December 2025 inspection, identifying significant Quality System Regulation (QSR)...



